Annual EBIT
-$132.28 M
-$8.74 M-7.07%
December 31, 2023
Summary
- As of February 8, 2025, PRLD annual earnings before interest & taxes is -$132.28 million, with the most recent change of -$8.74 million (-7.07%) on December 31, 2023.
- During the last 3 years, PRLD annual EBIT has fallen by -$73.51 million (-125.10%).
- PRLD annual EBIT is now -783.32% below its all-time high of -$14.97 million, reached on December 31, 2018.
Performance
PRLD EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$34.38 M
+$2.79 M+7.50%
September 30, 2024
Summary
- As of February 8, 2025, PRLD quarterly earnings before interest & taxes is -$34.38 million, with the most recent change of +$2.79 million (+7.50%) on September 30, 2024.
- Over the past year, PRLD quarterly EBIT has dropped by -$33.00 thousand (-0.10%).
- PRLD quarterly EBIT is now -399.36% below its all-time high of -$6.88 million, reached on September 30, 2019.
Performance
PRLD Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$143.26 M
-$991.00 K-0.70%
September 30, 2024
Summary
- As of February 8, 2025, PRLD TTM earnings before interest & taxes is -$143.26 million, with the most recent change of -$991.00 thousand (-0.70%) on September 30, 2024.
- Over the past year, PRLD TTM EBIT has dropped by -$5.76 million (-4.19%).
- PRLD TTM EBIT is now -1981.09% below its all-time high of -$6.88 million, reached on September 30, 2019.
Performance
PRLD TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
PRLD EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.1% | -0.1% | -4.2% |
| 3 y3 years | -125.1% | -3.0% | -16.0% |
| 5 y5 years | -783.3% | -3.0% | -16.0% |
PRLD EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -16.3% | at low | -18.1% | +8.0% | -26.0% | at low |
| 5 y | 5-year | -370.6% | at low | -253.1% | +8.0% | -743.8% | at low |
| alltime | all time | -783.3% | at low | -399.4% | +8.0% | -1981.1% | at low |
Prelude Therapeutics Incorporated EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$34.38 M(-7.5%) | -$143.26 M(+0.7%) |
| Jun 2024 | - | -$37.16 M(+8.2%) | -$142.27 M(+3.5%) |
| Mar 2024 | - | -$34.34 M(-8.1%) | -$137.50 M(+4.0%) |
| Dec 2023 | -$132.28 M(+7.1%) | -$37.38 M(+12.0%) | -$132.28 M(+3.1%) |
| Sep 2023 | - | -$33.38 M(+3.0%) | -$128.28 M(+2.4%) |
| Jun 2023 | - | -$32.40 M(+11.3%) | -$125.30 M(+2.4%) |
| Mar 2023 | - | -$29.11 M(-12.8%) | -$122.37 M(-0.9%) |
| Dec 2022 | -$123.54 M(+8.6%) | -$33.38 M(+9.8%) | -$123.54 M(+0.3%) |
| Sep 2022 | - | -$30.41 M(+3.2%) | -$123.17 M(-0.3%) |
| Jun 2022 | - | -$29.46 M(-2.7%) | -$123.59 M(+1.3%) |
| Mar 2022 | - | -$30.29 M(-8.2%) | -$122.06 M(+7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$113.73 M(+93.5%) | -$33.01 M(+7.1%) | -$113.73 M(+13.5%) |
| Sep 2021 | - | -$30.84 M(+10.4%) | -$100.17 M(+14.5%) |
| Jun 2021 | - | -$27.92 M(+27.1%) | -$87.48 M(+23.2%) |
| Mar 2021 | - | -$21.97 M(+13.0%) | -$70.99 M(+20.8%) |
| Dec 2020 | -$58.76 M(+109.1%) | -$19.45 M(+7.2%) | -$58.76 M(+18.9%) |
| Sep 2020 | - | -$18.14 M(+58.7%) | -$49.41 M(+29.5%) |
| Jun 2020 | - | -$11.44 M(+17.4%) | -$38.15 M(+42.8%) |
| Mar 2020 | - | -$9.74 M(-3.5%) | -$26.72 M(+57.3%) |
| Dec 2019 | -$28.11 M(+87.7%) | -$10.10 M(+46.6%) | -$16.98 M(+146.6%) |
| Sep 2019 | - | -$6.88 M | -$6.88 M |
| Dec 2018 | -$14.97 M | - | - |
FAQ
- What is Prelude Therapeutics Incorporated annual earnings before interest & taxes?
- What is the all time high annual EBIT for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual EBIT year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly EBIT year-on-year change?
- What is Prelude Therapeutics Incorporated TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated TTM EBIT year-on-year change?
What is Prelude Therapeutics Incorporated annual earnings before interest & taxes?
The current annual EBIT of PRLD is -$132.28 M
What is the all time high annual EBIT for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual earnings before interest & taxes is -$14.97 M
What is Prelude Therapeutics Incorporated annual EBIT year-on-year change?
Over the past year, PRLD annual earnings before interest & taxes has changed by -$8.74 M (-7.07%)
What is Prelude Therapeutics Incorporated quarterly earnings before interest & taxes?
The current quarterly EBIT of PRLD is -$34.38 M
What is the all time high quarterly EBIT for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly earnings before interest & taxes is -$6.88 M
What is Prelude Therapeutics Incorporated quarterly EBIT year-on-year change?
Over the past year, PRLD quarterly earnings before interest & taxes has changed by -$33.00 K (-0.10%)
What is Prelude Therapeutics Incorporated TTM earnings before interest & taxes?
The current TTM EBIT of PRLD is -$143.26 M
What is the all time high TTM EBIT for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high TTM earnings before interest & taxes is -$6.88 M
What is Prelude Therapeutics Incorporated TTM EBIT year-on-year change?
Over the past year, PRLD TTM earnings before interest & taxes has changed by -$5.76 M (-4.19%)